Recent Events in the Engelhardt Lab and Gene Therapy Center
Researchers in the Engelhardt Lab investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. (Read press releases: UI News Service; Big News Network.com; US News and World Report; News@nature.com)
Members of the Engelhardt lab spent a warm summer afternoon participating in a friendly (yet very competitive!) frisbee golf tournament between the Davidson, McCaffrey, McCray, Zabner and Welsh Labs (pictures)
The University of Iowa Research Foundation is issued a patent entitled "Adeno-Associated Virus Vectors and Uses Thereof"exclusively licensed to Targeted Genetics. (Read press release)
Nick Keiser receives ASGT Travel Award
Jennifer Marden successfully passes her Ph.D. thesis (Party to Congratulate Jennifer and say Farewell to Chenhong Guo)
Elab "Redoxers" Take to the Soccer Field
Liang (Neal) Zhang successfully passes his Ph.D. thesis
Ryan Driskell successfully passes his Ph.D. thesis
Engelhardt Lab bids farewell and best wishes to members
Maged Harraz successfully passes his Ph.D. thesis
Newly issued Targeted Genetics patent enables more effective delivery of recombinant AAV vectors
A novel approach is discovered for improving the efficiency with which adno-associated viral (AAV) vectors deliver genes to target cells (Read press release)
Engelhardt Named Head Of Anatomy And Cell Biology (Read press release) (see University of Iowa Carver College of Medicine Announcement)
Liang Zhang chosen for American Society of Gene Therapy "Excellence in Research Award"
Engelhardt Receives NIH MERIT Funding for Lung Stem Cell Study
(Read press release)
Ryan Driskell Receives Travel Award During the Annual Molecular Biology Retreat
Rana Dajani successfully passes her Ph.D. defense
New patent issued to the University of Iowa covers Targeted Genetics' approach to increase carrying capacity of AAV vectors
The patent covers the use of two AAV vectors to deliver DNA sequences that, once inside a cell, are used to produce or regulate a single protein. (Read press release)
Engelhardt and Fan Identify Damaging Mechanism in Transplants and Heart Attacks
A University of Iowa study suggests that inhibiting a certain protein involved in inflammation might be of therapeutic benefit in organ transplantation, heart attacks, and possibly stroke. (full story...)
Engelhardt Named Roy J. Carver Chair Of Molecular Medicine
Read the press release
John Engelhardt Named Interim Head Of Anatomy And Cell Biology
Read the press release
Intronn Awarded NIH Research Grant for SMaRT™ in Cystic Fibrosis
$500,000 Small Business Research Grant to fund collaborative venture between Intronn Inc. and Engelhardt Laboratory
Qiang Li successfully passes his Ph.D. defense
Dongsheng Duan and Ping celebrate their new lab at the University of Missouri-Columbia
Engelhardt Lab/Intronn, Inc. Collaboration on Trans-splicing Hits TV News on Channel 7
...Starring Dr. Xiaoming Liu!!
(use "QuickTime") (use "Windows media player") (use "Real player")
Gene Therapy Technology Licensed To Targeted Genetics
The University of Iowa Research Foundation has granted Targeted Genetics Corporation of Seattle a license to use certain gene therapy technologies developed at the UI. The agreement provides Targeted Genetics Corporation with access to technological developments from the laboratory of John Engelhardt, Ph.D., a UI Professor of Anatomy and Cell Biology and Internal Medicine, and Director of the UI Center for Gene Therapy of Cystic Fibrosis and Other Genetic Diseases. Research is focused on finding new uses for adeno-associated virus (AAV) as a vector for gene therapy. Targeted Genetics Corporation has also entered into a sponsored research agreement with the UI that will result in funding for ongoing AAV research in the Engelhardt laboratory. Full Story...
|
